SCHEMBL10464

SCHEMBL10464

O=C1CCSc2c(Cl)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
VHL P40337 1/20 0.46
ELOC Q15369 1/20 0.46
ELOB Q15370 1/20 0.46
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
HTT P42858 3/20 0.36
KDM4E B2RXH2 2/20 0.36
S100A4 P26447 1/20 0.34
CES1 P23141 2/20 0.34
NSD2 O96028 1/20 0.34
BCHE P06276 1/20 0.34
DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9171936 0.81 MAPT (0.41) MAPTALDH1A1L3MBTL1SMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL10513970 0.79 MAPT (0.40) MAPTALDH1A1L3MBTL1SMN1; SMN2MEN1
SCHEMBL7502 0.78 PARP10 (0.39) MAPTVHLELOCELOBALDH1A1
SCHEMBL6924 0.78 NOTUM (0.39) MAPTVHLELOCELOBALDH1A1
SCHEMBL8470635 0.78 VHL (0.46) MAPTVHLELOCELOBALDH1A1
SCHEMBL5635241 0.78 MEN1 (0.47) MAPTVHLELOCELOBALDH1A1
SCHEMBL21189321 0.76 VHL (0.38) MAPTVHLELOCELOBALDH1A1
SCHEMBL24188888 0.75 ALDH1A1 (0.44) VHLELOCELOBALDH1A1L3MBTL1
SCHEMBL23977277 0.75 VHL (0.44) MAPTVHLELOCELOBALDH1A1
SCHEMBL67587 0.74 VHL (0.54) MAPTVHLELOCELOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116496261-A 4- (1H) -imidazole derivative and medical application thereof 中国人民解放军军事科学院军事医学研究院 2023-07-28 CN disclosed
CN-115835863-A Oxaazabicyclic derivatives, preparation method and application thereof in medicines 江苏恒瑞医药股份有限公司 2023-03-21 CN disclosed
WO-2022007924-A1 OXA-AZABICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2022-01-13 WO disclosed
CN-108640901-B Thiochroman-4-ketone thiosemicarbazone compound and preparation method and application thereof 岭南师范学院 2020-04-28 CN disclosed
EP-2499146-B1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2016-09-21 EP disclosed
EP-2499146-B1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2016-09-21 EP disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
EP-0054233-B1 NOVEL BENZO(B)THIOPHENES, BENZO(B)FURANS, THIOCHROMANS AND CHROMANS, PROCESSES FOR THEIR PREPARATION AND ANTIMICROBIAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-09-24 EP disclosed
US-4468404-A MICROBIOCIDES SCHERING CORPORATION (US) 1984-08-28 US disclosed
US-4431816-A FUNGICIDES; BACTERICIDES SCHERING CORPORATION (US) 1984-02-14 US disclosed
US-4352808-A FUNGICIDES, BACTERICIDES, ANTIPROTOZOA AGENTS SCHERING CORPORATION (US) 1982-10-05 US disclosed
EP-0054233-A1 Novel benzo(b)thiophenes, benzo(b)furans, thiochromans and chromans, processes for their preparation and antimicrobial compositions containing them SCHERING CORPORATION (US) 1982-06-23 EP disclosed
US-4282229-A FOR DIABETIC COMPLICATIONS PFIZER INC. (US) 1981-08-04 US disclosed
US-4258054-A ANTIDIABETIC PFIZER INC. (US) 1981-03-24 US disclosed
US-4210756-A Tetrahydroquinoline hydantoins for chronic diabetic complications PFIZER INC. (US) 1980-07-01 US disclosed
US-4147795-A ENZYME INHIBITORS PFIZER INC. (US) 1979-04-03 US disclosed
US-4117230-A ANTIDIABETIC AGENTS PFIZER INC. (US) 1978-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES PI4KB, MTOR, PI4KA MAPT 965/4885VHL 2217/4885ELOC 3827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.